title: [Syphilis test proposed within the context of a programme to reduce mother/child HIV transmission: example of the Wassakara Health Care Center in Abidjan].
abstract: During the program MTCT+ set up in Abidjan by the national authorities with the assistance of the FSTI and FGSK, free screening and treatment of the syphilis infection were proposed to pregnant women. One test of agglutination on blades VDRL (Carbon Antigen Biotec the U.K.) and one TPHA test on plates for the positive VDRL (TPHA Nosticon Biomérieux F) were performed. Over the period from June 1999 to December 2001, 4 320 samples were taken. The laboratory observed 84 positive tests VDRL and 59 confirmed by TPHA, that is to say a syphilis seroprevalence (TPHA) of 1.4%. In addition 391 results were not available for various reasons (errors of numbering, haemolysed blood, absence of reagents, etc.) ie. 9.0%. Among the 59 positive women (TPHA), 30 came back for their result and 23 women were correctly treated (3 or 4 penicillin delay injections). In addition 7 partners received a complete treatment and 8 incomplete treatment. The cost of each detected and treated case rose approximately to 150 Euros, which is relatively low except in time/ staff and indirect costs for women. This study confirmed that all the activities of SMI must be integrated to have an efficient PTME programme. The biological assessment must be accessible as a whole, to minimize the additional costs and transportations. A training of all the personnel in 2002 helped to improve in an important way the results of the intervention in the center.
authors.affiliation: ESTHER (Ensemble pour une solidarité thérapeutique hospitalière en rèseau), 36 rue de Charenton, 75012 Paris, France. jean-loup.rey@esther.fr
authors.forename: J L
authors.initials: JL
authors.lastname: Rey
authors.forename: M
authors.initials: M
authors.lastname: Coulibaly
authors.forename: V
authors.initials: V
authors.lastname: Noba
mesh_terms: D015492:AIDS Serodiagnosis / Q000191:economics; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D007560:Cote d'Ivoire; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D008403:Mass Screening / Q000191:economics; D010406:Penicillins / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D012747:Sexual Partners; D013587:Syphilis / Q000517:prevention & control* / Q000635:transmission; D013588:Syphilis Serodiagnosis / Q000191:economics
chemical_list: D000900:Anti-Bacterial Agents; D010406:Penicillins